» Articles » PMID: 31485110

Carbimazole-induced Anaphylactic Shock: A Case Report

Overview
Specialty Critical Care
Date 2019 Sep 6
PMID 31485110
Authors
Affiliations
Soon will be listed here.
Abstract

Key Messages: Patient on carbimazole should be aware of all side effects including rare side effects like anaphylactic shock. Studies are required to identify risk factors and new drugs for carbimazole allergy patients. Patient with thyrotoxicosis should also be screened for autoimmune thyrotoxicosis.

How To Cite This Article: Keyal NK, Thapa S, Yadav MK. Carbimazole-induced Anaphylactic Shock: A Case Report. Indian J Crit Care Med 2019;23(8):380-381.

References
1.
Simons F, Ardusso L, Bilo M, El-Gamal Y, Ledford D, Ring J . World Allergy Organization anaphylaxis guidelines: summary. J Allergy Clin Immunol. 2011; 127(3):587-93.e1-22. DOI: 10.1016/j.jaci.2011.01.038. View

2.
Mavrakanas T, Bouatou Y, Samer C, de Seigneux S, Meyer P . Carbimazole-induced, ANCA-associated, crescentic glomerulonephritis: case report and literature review. Ren Fail. 2013; 35(3):414-7. DOI: 10.3109/0886022X.2012.760356. View

3.
Haq I, Sosin M, Wharton S, Gupta A . Carbimazole-induced lupus. BMJ Case Rep. 2013; 2013. PMC: 3604011. DOI: 10.1136/bcr-2012-007596. View

4.
Akmal A, Kung J . Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity. Expert Opin Drug Saf. 2014; 13(10):1397-406. DOI: 10.1517/14740338.2014.953796. View

5.
Attard C, Gruppetta M, Vassallo J, Vella S . Carbimazole-induced exudative pleural effusions. BMJ Case Rep. 2016; 2016. PMC: 4840707. DOI: 10.1136/bcr-2016-215080. View